echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > In February 2019, the growth rate of China's pharmaceutical manufacturing industry accelerated

    In February 2019, the growth rate of China's pharmaceutical manufacturing industry accelerated

    • Last Update: 2019-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network industry trends] recently, the National Bureau of statistics released the information to interpret China's purchasing manager index in February 2019 In February, the industrial structure of high-tech manufacturing continued to be optimized Among them, the PMI of pharmaceutical manufacturing industry and computer communication electronic equipment manufacturing industry are higher than that of last month and the overall level of manufacturing industry, with a rapid growth rate The pharmaceutical manufacturing industry is an important part of the pharmaceutical industry, which has the characteristics of high investment, high risk, high return and long R & D cycle In recent years, with the promotion of favorable measures in the pharmaceutical industry, the acceleration of the aging process, the opening of the two child policy in an all-round way, and the promotion of pharmaceutical consumption upgrading by the big health industry and other factors, the demand market for domestic pharmaceutical products has been growing, and the pharmaceutical industry has continued to develop steadily In 2019, the effect of consistency evaluation and volume purchasing gradually appears, more and more pharmaceutical enterprises are transforming and upgrading, and the process of restructuring and integration in the industry will be further accelerated However, the industry said that China's pharmaceutical manufacturing industry is still facing many challenges On the one hand, it is difficult to cross technical barriers For example, in terms of the technical level of chemical pharmacy, due to the late start and weak technical level of China's pharmaceutical industry, there is a significant gap between China's pharmaceutical industry and the international mature market, and in terms of the research and development of chemical innovative drugs, foreign enterprises with strong advantages and technical advantages have a serious monopoly, while China's research and development investment in chemical medicine is seriously insufficient, which is still in the low-level, low added value imitation stage This R & D innovation ability needs to be improved On the other hand, with the increasingly prominent environmental protection problems, the quality standards and environmental protection standards of chemical APIs and preparation products continue to improve At the same time, under the drug price control policy, drugs are facing substantial price cuts, and drug companies are also facing greater survival pressure The industry is survival of the fittest, and drug companies must carry out transformation and upgrading Industry data shows that in 2019, the sales revenue of China's pharmaceutical manufacturing industry will reach 2833.3 billion yuan; in the next five years (2019-2023), the annual compound growth rate will be about 8.53%, and in 2023, it will reach 3931.3 billion yuan In 2019, the total profit of China's pharmaceutical manufacturing industry will reach 343 billion yuan; in the next five years, the annual compound growth rate will be about 12.39%, and in 2023, it will reach 547.3 billion yuan It can be seen that the future development space of pharmaceutical manufacturing industry is still large In addition, the paper points out that the price of some international commodities has risen, and the price index has both recovered The purchase price index and ex factory price index of main raw materials were 51.9% and 48.5%, higher than 5.6 and 4.0 percentage points of last month respectively Among them, the purchase price index and ex factory price index of major raw materials in petroleum processing, chemical raw materials and chemical products, ferrous metal smelting and rolling processing industries rose significantly on a month on month basis According to the ex factory price index of industrial producers released by the National Bureau of statistics on February 15, in January 2019, the prices of chemical raw materials and chemical products manufacturing industry dropped by 2% year on year and 1.5% month on month From a month on month perspective, the chemical raw materials and chemical products manufacturing industry decreased by 1.5% and narrowed by 0.4%; from a year-on-year perspective, the chemical raw materials and chemical products manufacturing industry decreased by 2.0% It is understood that the main factors affecting the price trend in China are imported inflation, demand pull and abundant liquidity From the perspective of imported factors, the price of international bulk commodities rebounded and imported inflation pressure increased As the decline of commodity price will be transmitted to the industrial production field, the product price will rise, or the consumer price trend will be affected From the perspective of demand factors, China is in the period of economic structural transformation, the economic growth mode which was driven by extensive investment is changing in the past, the driving force of investment on price rise is weakening, the consumer demand is stable and slowing down, and the consumer price lacks the driving force of rising From the perspective of liquidity, the steady monetary policy will continue to be implemented in 2019, which means that the possibility of raising prices due to the flood of liquidity is relatively small According to the industry, on the whole, it is less likely that China's prices will rise sharply in 2019 Neither CPI nor PPI will rise significantly.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.